title: Low-dose naltrexone to prevent intolerable morphine adverse events: a forgotten remedy for a neglected, global clinical need.
authors: ISAL Foundation, Institute for Research on Pain, Rimini, Italy.
authors: William
authors: W
authors: Raffaeli
authors: Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, USA.
authors: Paola
authors: P
authors: Indovina
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D059350:Chronic Pain / Q000188:drug therapy / Q000453:epidemiology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009020:Morphine / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D009271:Naltrexone / Q000008:administration & dosage*; D009292:Narcotic Antagonists / Q000008:administration & dosage*; D009369:Neoplasms / Q000188:drug therapy / Q000453:epidemiology
chemical_list: D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D009271:Naltrexone; D009020:Morphine